BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 18306533)

  • 1. Expression of cyclin D1 in endometrial hyperplasia and endometrial carcinoma.
    Choudhury M; Bansal S
    Indian J Pathol Microbiol; 2007 Oct; 50(4):708-10. PubMed ID: 18306533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables.
    Ozuysal S; Oztürk H; Bilgin T; Filiz G
    Arch Gynecol Obstet; 2005 Feb; 271(2):123-6. PubMed ID: 14740230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas.
    Nikaido T; Li SF; Shiozawa T; Fujii S
    Cancer; 1996 Sep; 78(6):1248-53. PubMed ID: 8826947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis.
    Nishimura Y; Watanabe J; Jobo T; Kato N; Fujisawa T; Kamata Y; Kuramoto H
    Anticancer Res; 2004; 24(4):2185-91. PubMed ID: 15330159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential diagnosis of endometrial hyperplasia and carcinoma by computerized image cytometry of cell proliferation, apoptosis and Bcl-2 expression.
    Mora LB; Diaz JI; Cantor AB; Nicosia SV
    Ann Clin Lab Sci; 1999; 29(4):308-15. PubMed ID: 10528831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables.
    Kyushima N; Watanabe J; Hata H; Jobo T; Kameya T; Kuramoto H
    J Cancer Res Clin Oncol; 2002 Jun; 128(6):307-12. PubMed ID: 12073048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoexpression of Cyclin D1 and PTEN in Various Endometrial Pathologies.
    Shawana S; Kehar SI; Masood S; Aamir I
    J Coll Physicians Surg Pak; 2016 Apr; 26(4):277-82. PubMed ID: 27097697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical pattern of protein P21, cyclin D1 and cyclin E in endometrial hyperplasia.
    Brucka A; Bartczak P; Ratyńska M; Sporny S
    Pol J Pathol; 2009; 60(1):19-25. PubMed ID: 19670700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive derailment of cell cycle regulators in endometrial carcinogenesis.
    Horrée N; van Diest PJ; van der Groep P; Sie-Go DM; Heintz AP
    J Clin Pathol; 2008 Jan; 61(1):36-42. PubMed ID: 17483252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CyclinD1, a prominent prognostic marker for endometrial diseases.
    Liang S; Mu K; Wang Y; Zhou Z; Zhang J; Sheng Y; Zhang T
    Diagn Pathol; 2013 Aug; 8():138. PubMed ID: 23947899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D1 and Ki-67 expression in normal, hyperplastic and neoplastic endometrium.
    Shevra CR; Ghosh A; Kumar M
    J Postgrad Med; 2015; 61(1):15-20. PubMed ID: 25511212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ability of endometrial biopsies with atypical complex hyperplasia to guide surgical management.
    Miller C; Bidus MA; Pulcini JP; Maxwell GL; Cosin JA; Rose GS
    Am J Obstet Gynecol; 2008 Jul; 199(1):69.e1-4. PubMed ID: 18241812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of curettage in diagnosis of endometrial hyperplasia.
    Xie X; Lu WG; Ye DF; Chen HZ; Fu YF
    Gynecol Oncol; 2002 Jan; 84(1):135-9. PubMed ID: 11748989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AgNORs in endometrial lesions.
    Kaushik R; Sharma S; Mahajan V; Gulati A; Sharma BB
    Indian J Pathol Microbiol; 1999 Oct; 42(4):451-4. PubMed ID: 11127377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Difficulties and mistakes in the diagnosis of atypical endometrial hyperplasia].
    Kxmel'nitskaia NM; Neĭshtadt EL; Khalimdzhanov ZK
    Arkh Patol; 2006; 68(6):39-42. PubMed ID: 17290894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial hyperplasia involving endometrial polyps: report of a series and discussion of the significance in an endometrial biopsy specimen.
    Kelly P; Dobbs SP; McCluggage WG
    BJOG; 2007 Aug; 114(8):944-50. PubMed ID: 17565613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cyclin D1 in normal, metaplastic, hyperplastic endometrium and endometrioid carcinoma suggests a role in endometrial carcinogenesis.
    Ruhul Quddus M; Latkovich P; Castellani WJ; James Sung C; Steinhoff MM; Briggs RC; Miranda RN
    Arch Pathol Lab Med; 2002 Apr; 126(4):459-63. PubMed ID: 11900573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study.
    Vasef MA; Brynes RK; Sturm M; Bromley C; Robinson RA
    Mod Pathol; 1999 Apr; 12(4):412-6. PubMed ID: 10229506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of LH/hCG receptors in endometrial hyperplasia and carcinoma in anovulatory women.
    Konishi I; Koshiyama M; Mandai M; Kuroda H; Yamamoto S; Nanbu K; Komatsu T; Matsushita K; Rao CV; Mori T
    Gynecol Oncol; 1997 May; 65(2):273-80. PubMed ID: 9159337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endometrial hyperplasia and carcinoma in situ].
    Ganchev S; Maĭnkhard K
    Akush Ginekol (Sofiia); 1997; 36(3):47-50. PubMed ID: 9618961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.